Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed Or Refractory Multiple Myeloma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03731832
What this trial is testing

Pomalidomide, Ixazomib, and Dexamethasone With or Without Intensification by Cyclophosphamide in Relapsed or Refractory Multiple Myeloma

Who this might be right for
Refractory Multiple Myeloma
GWT-TUD GmbH 66
Early research (Phase 1)Study completedNCT00718601
What this trial is testing

Safety and Dose Study of GRN163L and Velcade to Treat Patients With Refractory or Relapsed Myeloma

Who this might be right for
Multiple Myeloma
Geron Corporation 40
Early research (Phase 1)Study completedNCT04136756
What this trial is testing

NKTR-255 in Relapsed/Refractory Multiple Myeloma & Non-Hodgkin Lymphoma

Who this might be right for
Multiple MyelomaNon-Hodgkin LymphomaIndolent Non-Hodgkin Lymphoma
Nektar Therapeutics 30
Testing effectiveness (Phase 2)Study completedNCT02977494
What this trial is testing

Daratumumab in Combination With Bortezomib and Dexamethasone in Subjects With Relapsed or Relapsed and Refractory Multiple Myeloma and Severe Renal Impairment

Who this might be right for
Multiple Myeloma
Universitätsklinikum Hamburg-Eppendorf 22
Early research (Phase 1)Ended earlyNCT03287908
What this trial is testing

Assess AMG 701 Montherapy, or in Combination With Pomalidomide, With or Without, Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Relapsed/Refractory Multiple Myeloma
Amgen 174
Early research (Phase 1)Looking for participantsNCT06433947
What this trial is testing

Study to Assess Safety and Tolerability of OPN-6602 in Subjects With Relapsed and/or Refractory Multiple Myeloma

Who this might be right for
Relapsed Multiple MyelomaRefractory Multiple Myeloma
Opna Bio LLC 130
Early research (Phase 1)WithdrawnNCT04998747
What this trial is testing

Subcutaneous (SC) AMG 701 in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

Who this might be right for
Relapsed/Refractory Multiple Myeloma
Amgen
Early research (Phase 1)Ended earlyNCT03168438
What this trial is testing

Letetresgene Autoleucel Engineered T Cells Alone and in Combination With Pembrolizumab in NY-ESO-1 Positive Multiple Myeloma

Who this might be right for
Neoplasms
GlaxoSmithKline 6
Testing effectiveness (Phase 2)Study completedNCT01447914
What this trial is testing

Tivantinib in Treating Patients With Relapsed, or Relapsed and Refractory Multiple Myeloma

Who this might be right for
Refractory Multiple Myeloma
National Cancer Institute (NCI) 16
Early research (Phase 1)Looking for participantsNCT06622005
What this trial is testing

SX-682 in Combination With Carfilzomib, Daratumumab-Hyaluronidase, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Recurrent Multiple MyelomaRefractory Multiple Myeloma
Roswell Park Cancer Institute 15
Testing effectiveness (Phase 2)Study completedNCT03732703
What this trial is testing

Myeloma-Developing Regimens Using Genomics (MyDRUG)

Who this might be right for
Relapsed Refractory Multiple Myeloma
Multiple Myeloma Research Consortium 103
Early research (Phase 1)Study completedNCT02182141
What this trial is testing

An Dose Escalation Study of BIBF 1120 Administered in Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Boehringer Ingelheim 17
Early research (Phase 1)Study completedNCT01533194
What this trial is testing

Viral Therapy in Treating Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Light Chain Deposition DiseaseRefractory Plasma Cell Myeloma
National Cancer Institute (NCI) 12
Large-scale testing (Phase 3)UnknownNCT02336386
What this trial is testing

CDD Plus Bortezomib or CDDin Relapsed or Refractory Multiple Myeloma With Extramedullary Plasmacytoma

Who this might be right for
Extramedullary Plasmacytoma
Beijing Chao Yang Hospital 100
Early research (Phase 1)Study completedNCT04093596
What this trial is testing

Safety and Efficacy of ALLO-715 BCMA Allogenic CAR T Cells in in Adults With Relapsed or Refractory Multiple Myeloma (UNIVERSAL)

Who this might be right for
Relapsed/Refractory Multiple Myeloma
Allogene Therapeutics 73
Testing effectiveness (Phase 2)Ended earlyNCT00227682
What this trial is testing

Arsenic Trioxide, Thalidomide, Dexamethasone, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
OHSU Knight Cancer Institute 2
Testing effectiveness (Phase 2)Study completedNCT00022282
What this trial is testing

AE-941 in Treating Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
AEterna Zentaris
Early research (Phase 1)Study completedNCT01645930
What this trial is testing

Phase 1 Pharmacokinetic Study of Oral Ixazomib Plus Lenalidomide and Dexamethasone in Adult Asian Participants With Relapsed and/or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Millennium Pharmaceuticals, Inc. 43
Early research (Phase 1)Ended earlyNCT00912899
What this trial is testing

Noscapine HCl (CB3304 ) in Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Refractory Multiple Myeloma
Cougar Biotechnology, Inc. 12
Testing effectiveness (Phase 2)UnknownNCT00036712
What this trial is testing

Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation

Who this might be right for
Chronic Myeloproliferative DisordersKidney CancerLeukemia+9 more
Medical College of Wisconsin 80
Next Page